The independent source for health policy research, polling, and news.
61-80 of 238 results
Eli Lilly's news that it plans to cut insulin costs for patients will help, not hinder, the recent efforts in California and by entrepreneurs such as Mark Cuban to offer lower-cost alternatives, drug pricing experts said.
Colorado’s proposed legislation to cap the copay for the EpiPen is part of a nationwide trend as more states try to shield patients from skyrocketing drug prices.
Insurers, employers, and taxpayers will all be affected as drug manufacturers move these products to the commercial market.
KHN gives readers a chance to comment on a recent batch of stories.
Another effort to make upfront cost comparisons possible in an industry known for its opaqueness: an online tool for consumers to get some idea of what they may pay for medical care.
Coal mining ended in Germany’s Saarland a decade ago, but the transition away from coal has been smoother than in West Virginia, which has more medical debt than any state in America.
Some insurers and employers are tapping into assistance programs meant for individual patients. The concern: Some costly drugs could be harder for patients to access.
In August, Congress approved a $35 cap on what seniors will pay for insulin, but that change came too late to add to the online tool that helps Medicare beneficiaries compare dozens of drug and medical plans. Federal officials say beneficiaries who use insulin will have the opportunity to switch plans after open enrollment ends Dec. 7.
State employees could receive checks ranging from $50 to thousands of dollars if they choose the right provider.
As private equity groups are swarming into aging America’s eye care, the consolidation is costing the U.S. health care system and patients more money.
In this episode, Julie Rovner, chief Washington correspondent for KHN, guides listeners through decades of dealings between Congress and Big Pharma.
The U.S. health system now produces debt on a mass scale, a new investigation shows. Patients face gut-wrenching sacrifices.
Even the savviest Medicare drug plan shoppers can get a shock when they fill prescriptions: That great deal on medications is no bargain after prices go up.
The Fierro family owed a Yuma, Arizona, hospital more than $7,000 for care given to mom and dad, so when a son dislocated his shoulder, they headed to Mexicali. The care was quick, good, and affordable.
Even a personal finance expert can get stuck with a huge unexpected bill for a drug. Listen up for what you need to know about "copay accumulators."
Years in the making, a new federal law against surprise medical bills took effect Jan. 1.
The American Medical Association and American Hospital Association are not arguing to halt the law that protects patients from unexpected bills from providers they didn’t know were outside their insurance network. Instead, they want to change the rules for the mediators who will settle the dispute between insurers and providers.
As hospital systems and insurers adjust to the pandemic, their contract negotiations grow increasingly fraught. Contracts for in-network care are ending without a new deal, leaving patients suddenly with out-of-network bills or scrambling to find new in-network providers.
A new California law requires health insurance companies to notify consumers how much remains on their deductibles and how close they are to their annual out-of-pocket spending limits.
© 2026 KFF